Workflow
Medical Equipment Stock Jumps on Upgrade
MYGNMyriad(MYGN) Schaeffers Investment Research·2025-03-12 14:40

Medical equipment stock Myriad Genetics Inc (NASDAQ:MYGN) was last seen up 9.8% at 11.25,afteranupgradefromPiperSandlerto"overweight"from"neutral,"withaprice−targethiketo11.25, after an upgrade from Piper Sandler to "overweight" from "neutral," with a price-target hike to 12.50 from 11.50.Thefirmnotedanattractiveentrypointfollowingthestock′sextendedpullback,andcitedtheCEOchange,asSamRahawillreplacePaulDiazonApril30. Today′ssurgebuildsonMYGN’s6.811.50. The firm noted an attractive entry point following the stock's extended pullback, and cited the CEO change, as Sam Raha will replace Paul Diaz on April 30. Today's surge builds on MYGN’s 6.8% gain in the previous session, following its March 10 five-year low of 9.24. The stock broke below support at $12 ...